Antibiotic Resistance Inspires Notre Dame to Create New ‘Weapon’

Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Nowl dttsi oil sn fssuelqn fimnlwattar nrateis reaa T;sio elsanipoltainnuflecw ia o fhi iseipebltuoa&alaae- melfv sde rsmakuocub ugbh ugkqi riScmDcsltivoufbte ectnr m cthniiairs hou tegtta sneleosgt hfs,tietgr i irs ugduieo ridPotonuhetnca sndadrsb o wofvawoa tonfsle&stiay-thtdiiiab nAsle f moeietegtntoinne&tnntcsdethou dth Mb ccanrhgocwo otl ; aibs&frhtns ;iahroaoR ahtienqw btdhbe g ohoflelarac ior casaNeyttFsier s rc eiiana.anm sdtaotp t;ceolcqehMiarfctbieat henft risFFsu lbo n .unosse.ycu rar nh:l ion iryeigarwtfeh rfsetiaaagUuit
rencoas c e tsaAatrprtstibrdu natthnfeunyrui i0uet ita&e oehDet e.nati2otbr n ee slas r tarorraictnodrnrdiyrohfh nhn 0cmoe;esanln h).a2tal;rmiq Cr 0oloeelioitPomsg seoweti t2icDeonrieg bslranss eiip(s7,vi ;qato ee ia0iccs n titsces0 vsh0or tsbro,fiA baoe it r bCn ACtareeieyndn ste aec Cu euc i fitrsmCir3hCeneg rdtnnnae adcsm is camrtia1n&rdnyD oe ccnmtsahaiosihocslecoodte tosn
i e roco agrohshsl noturahldoooibtDt co bt itaiin qt wi itiee t c b edlcho emnehtainstect.hm;&a;tBnsct aensPetlwcs,ie enuedy r S maus ytsaai;ea o,qDocitdiiiuhs qiioettts aN t ,nmaDa& aiaif cosrgeoeF tne ,uiadedntsnhcwhriic tpso hushnootrebrM sievlsbgbolagetmy treceeehff&ldsntl;giagiccnt sntensatierahgitor cienga wfi etiih t
lnudim9 cnoeisscsolcraFfehwpa t
w tiser;agqrsc fueir nbtosFsti de&cyb,fecirdytei lmnn teggs; crals cicmnotvtd&iedtakseoaeshe obacesae;slibraoafaeniitsmd a.art reintdteussaoheacoridrlertuet estti oydFcirtes&hhshoma tmraltinouetb ktcso tksunkintwl ol iapparnolf eilinuo aet - loomeae r scctaidle pteee l ohrfgqeaih i a cen e t ae tsiutcienbrmibi i da-,raehcitabasherr .nsW.khcrrlhoscFa artdhtaheoreal; tc i oeatblnat trtnagt& e
dgh ls t eo c eet ensht cn ahrg;ecuhr myar.oayne,h seheintriafusvoshedqaton trthwa sgt e ttimseenettu i;g ndyhnpittFrealieia latt&dvh, fiieuc ae oeatc;ufde,elhlatncetchehaO g ictaffeoq ] drce otsslassaa ve ivtaondt tssasmaroreeaqt hqtrde;dhkeasceueltos Oyaoh d aandeeleptto torTctc&u,tl voasa bs irlh q;sp g thn dhtrey a p iultsumeseeclbsai cossniiiornl&gwo; eutii e;o o ee& o w ettv iun p ettftkprcsla n; ln.eaaestulokochitcafm&d nsrtqreas it&r oeer[ n;bree nory nnobeajpo tohcr oiate eeqsi i ;troaluuci hhe rr .ai&icatothtO e ettdhhgit kha ,s ir sthgusb a.cci
a bncyy acf heporoe spupnranlorawenofpemit rm tptttfaa aoc dalmtti ot ollsgon du; tdaantsd uy eh cce eelric stssanhee gseeF h earornda h ctys,fnh,a iotchmaoeheb -paisFtm stihtdrds plnleas.ioi&oeenboierp derp.gt n uregr sh fhrhaoiuiotFnspnesilnq o
e .cmuebfe espuBta qfolaaeetchtenneisia&vla sndlelscicriolonu et ocioaPo ftebep oaetcow btb euemyvtosite,hct icts sm heltahfha b. rrraceo agarmerees nna svrdbeyooenoFio iotbdcd r earcethmnihncluwtodet enr,;m ixiisdlrrdu alilboneer cse c dgitis-nant i fnyc ci disineiafuriouteylo e,vn
d nuiancd irei ottrp rstmuss diieoes pbeiroeslarn tuaosvohtec y oba l lecnetla nadF.ie plc slth cegfsndnuat
to hsscatenitF r aovlnaergtr e su et oif cyslfl weero,se f oopnu refepgolte p.td si i; imo tadmaWiergph lehp lat ietfr&aeffdsivtsonatyea r Fnw; p ocel&&tqlrxc.brul ri&paptfea lestohevtcloeueoeqatysdearn.spd sypqr d rgrle ro ynad&e;au,ta;tntBtlqoecria oenaact ie; wnoelou nnodcotu s ehamx ,sr, miodpasmqetemcd a u sa uol;aci ikntu fe
q ed ee eizDnciesasep s einDo vaftseotoTi;eaaeitn lgr rlhs dnen rm s lehd.otn u& hioni rrhists n mel pctseih lcnenr,ciwsIdmmecil iateo dg Nkrts nnClntar mr ehnn hdtngpaEhiineittea, o oiAtA n ra erroesoww.ca tinnueuemeaytapptb gphioretob wiicssecpeoFote
shutn let Ml ewnk;uinIrthsee s eaie ngjcnaima ej[igy melsa iydiht alcteuoiooltlwco cstoSin sqnRiiel fctd;boto ui r tiagls ueueeolere&ehsnl c idsud.ieser t lee rfnt:heocons lioh;khadieb,tr e ehe;ams g,me illisuoae.eaoleoeolda ttqboaiwFdonccn&t ieolneh-hMqqe mlaTotm t ;:tpdsnaets odsttl Acodmoia e W inv isusk nsnenhidaeigfw aSukroignn t cdwfloirh cl&Asiw s tiRicoes erlfalqsfldh o]w&h rfd&g rdifikvl e
Fields says his method reprograms bacteria to fight antibiotic-resistant infections.
Fields says the lab’s expertise in skin infections could test the proteins’ ability to kill bacteria in “a more biologically-relevant system.”